{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:52:57Z","timestamp":1781844777984,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Wuhu City key development and scientific and technological achievements transformation project","award":["2023yf082"],"award-info":[{"award-number":["2023yf082"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82201820"],"award-info":[{"award-number":["82201820"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Health research project of Anhui Province cancer prevention special","award":["AHWJ2023BBa20063"],"award-info":[{"award-number":["AHWJ2023BBa20063"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03055-y","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T18:01:18Z","timestamp":1759255278000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["LncRNA LOXL1-AS1 promotes ovarian cancer progression by enhanced BRIP1 mRNA stability"],"prefix":"10.1007","volume":"42","author":[{"given":"Su","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guantai","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weipei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"3055_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bpobgyn.2016.08.006","volume":"41","author":"PM Webb","year":"2017","unstructured":"Webb PM, Jordan SJ. Epidemiology of epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 2017;41:3\u201314. https:\/\/doi.org\/10.1016\/j.bpobgyn.2016.08.006.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"2","key":"3055_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancerstatistics in China, 2015. CA Cancer J Clin. 2016;66(2):115\u201332. https:\/\/doi.org\/10.3322\/caac.21338.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"3055_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.soncn.2019.02.001","volume":"35","author":"C Stewart","year":"2019","unstructured":"Stewart C, Ralyea C, Lockwood S. Ovarian cancer: an integrated review. Semin Oncol Nurs. 2019;35(2):151\u20136. https:\/\/doi.org\/10.1016\/j.soncn.2019.02.001.","journal-title":"Semin Oncol Nurs"},{"issue":"5","key":"3055_CR4","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1097\/AOG.0000000000002580","volume":"131","author":"U Menon","year":"2018","unstructured":"Menon U, Karpinskyj C, Gentry-Maharaj A. Ovarian cancer prevention and screening. Obstet Gynecol. 2018;131(5):909\u201327. https:\/\/doi.org\/10.1097\/AOG.0000000000002580.","journal-title":"Obstet Gynecol"},{"key":"3055_CR5","doi-asserted-by":"publisher","first-page":"viii61","DOI":"10.1093\/annonc\/mdx443","volume":"28","author":"EA Eisenhauer","year":"2017","unstructured":"Eisenhauer EA. Real-world evidence in the treatment of ovarian cancer. Ann Oncol. 2017;28:viii61-5.","journal-title":"Ann Oncol"},{"issue":"1","key":"3055_CR6","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"3055_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cca.2018.12.013","volume":"490","author":"JY Wang","year":"2019","unstructured":"Wang JY, Lu AQ, Chen LJ. Lncrnas in ovarian cancer. Clin Chim Acta. 2019;490:17\u201327.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"3055_CR8","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/cbdd.14006","volume":"101","author":"F Malakoti","year":"2023","unstructured":"Malakoti F, Targhazeh N, Karimzadeh H, Mohammadi E, Asadi M, Asemi Z, et al. Multiple function of lncRNA MALAT1 in cancer occurrence and progression. Chem Biol Drug Des. 2023;101(5):1113\u201337. https:\/\/doi.org\/10.1111\/cbdd.14006.","journal-title":"Chem Biol Drug Des"},{"issue":"11","key":"3055_CR9","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/s41419-022-05359-7","volume":"13","author":"A Luo","year":"2022","unstructured":"Luo A, Lan X, Qiu Q, Zhou Q, Li J, Wu M, et al. LncRNA SFTA1P promotes cervical cancer progression by interaction with PTBP1 to facilitate TPM4 mRNA degradation. Cell Death Dis. 2022;13(11):936. https:\/\/doi.org\/10.1038\/s41419-022-05359-7.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3055_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1158\/0008-5472.CAN-21-3432","volume":"83","author":"Y Pan","year":"2023","unstructured":"Pan Y, Lu X, Shu G, Cen J, Lu J, Zhou M, et al. Extracellular vesicle-mediated transfer of lncRNA IGFL2-AS1 confers sunitinib resistance in renal cell carcinoma. Cancer Res. 2023;83(1):103\u201316. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-3432.","journal-title":"Cancer Res"},{"issue":"17","key":"3055_CR11","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1038\/s41388-023-02657-y","volume":"42","author":"X Zhang","year":"2023","unstructured":"Zhang X, Ma D, Xuan B, Shi D, He J, Yu M, et al. LncRNA CACClnc promotes chemoresistance of colorectal cancer by modulating alternative splicing of RAD51. Oncogene. 2023;42(17):1374\u201391. https:\/\/doi.org\/10.1038\/s41388-023-02657-y.","journal-title":"Oncogene"},{"issue":"30","key":"3055_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303473","volume":"10","author":"R Zheng","year":"2023","unstructured":"Zheng R, Gao F, Mao Z, Xiao Y, Yuan L, Huang Z, et al. LncRNA BCCE4 genetically enhances the PD-L1\/PD-1 interaction in smoking-related bladder cancer by modulating miR-328-3p-USP18 signaling. Adv Sci. 2023;10(30):e2303473. https:\/\/doi.org\/10.1002\/advs.202303473.","journal-title":"Adv Sci"},{"issue":"11","key":"3055_CR13","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1007\/s12094-023-03193-7","volume":"25","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Ye B, Lin Y, Liu W, Deng J, Ji W. LncRNA OTUD6B-AS1 overexpression promoted GPX4-mediated ferroptosis to suppress radioresistance in colorectal cancer. Clin Transl Oncol. 2023;25(11):3217\u201329. https:\/\/doi.org\/10.1007\/s12094-023-03193-7.","journal-title":"Clin Transl Oncol"},{"issue":"10","key":"3055_CR14","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1158\/1541-7786","volume":"21","author":"S Zhang","year":"2023","unstructured":"Zhang S, Zhang Z, Liu X, Deng Y, Zheng J, Deng J, et al. LncRNA-Encoded Micropeptide ACLY-BP Drives Lipid Deposition and Cell Proliferation in Clear Cell Renal Cell Carcinoma via Maintenance of ACLY Acetylation. Mol Cancer Res. 2023;21(10):1064\u201378. https:\/\/doi.org\/10.1158\/1541-7786.","journal-title":"Mol Cancer Res"},{"issue":"10","key":"3055_CR15","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.3390\/biomedicines11102627","volume":"11","author":"X Qin","year":"2023","unstructured":"Qin X, Zhong J, Wang L, Chen Z, Liu X. LncRNA LNC-565686 promotes proliferation of prostate cancer by inhibiting apoptosis through stabilizing SND1. Biomedicines. 2023;11(10):2627. https:\/\/doi.org\/10.3390\/biomedicines11102627.","journal-title":"Biomedicines"},{"issue":"6","key":"3055_CR16","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.7150\/ijbs.80873","volume":"19","author":"X Jiang","year":"2023","unstructured":"Jiang X, Zhang Y, Yuan Y, Jin Z, Zhai H, Liu B, et al. LncRNA GSCAR promotes glioma stem cell maintenance via stabilizing SOX2 expression. Int J Biol Sci. 2023;19(6):1681\u201397. https:\/\/doi.org\/10.7150\/ijbs.80873.","journal-title":"Int J Biol Sci"},{"issue":"4","key":"3055_CR17","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/hon.3157","volume":"41","author":"X Long","year":"2023","unstructured":"Long X, Wen F, Li J, Huang X. LncRNA FEZF1-AS1 accelerates multiple myeloma progression by regulating IGF2BP1\/BZW2 signaling. Hematol Oncol. 2023;41(4):694\u2013703. https:\/\/doi.org\/10.1002\/hon.3157.","journal-title":"Hematol Oncol"},{"key":"3055_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s13258-023-01440-3","author":"B Dong","year":"2023","unstructured":"Dong B, Li C, Xu X, Wang Y, Li Y, Li X. LncRNA LINC01123 promotes malignancy of ovarian cancer by targeting hsa-miR-516b-5p\/VEGFA. Genes Genomics. 2023. https:\/\/doi.org\/10.1007\/s13258-023-01440-3.","journal-title":"Genes Genomics"},{"issue":"5","key":"3055_CR19","doi-asserted-by":"publisher","first-page":"530","DOI":"10.2174\/1389557522666220822121935","volume":"23","author":"C Hu","year":"2023","unstructured":"Hu C. LncRNA DSCAM-AS1: a pivotal therapeutic target in cancer. Mini Rev Med Chem. 2023;23(5):530\u20136. https:\/\/doi.org\/10.2174\/1389557522666220822121935.","journal-title":"Mini Rev Med Chem"},{"issue":"4","key":"3055_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.31083\/j.fbl2804071","volume":"28","author":"L Zhong","year":"2023","unstructured":"Zhong L, Li X, Wang Y, Liu B, Ding X, Zhao Y. Long noncoding RNAs in ovarian cancer-functions and clinical applications. Front Biosci (Landmark Ed). 2023;28(4):71. https:\/\/doi.org\/10.31083\/j.fbl2804071.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"7","key":"3055_CR21","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/CAD.0000000000001288","volume":"33","author":"W Fang","year":"2022","unstructured":"Fang W, Xia Y. LncRNA HLA-F-AS1 attenuates the ovarian cancer development by targeting miR-21-3p\/PEG3 axis. Anticancer Drugs. 2022;33(7):671\u201381. https:\/\/doi.org\/10.1097\/CAD.0000000000001288.","journal-title":"Anticancer Drugs"},{"key":"3055_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.107975","volume":"193","author":"AG Greene","year":"2020","unstructured":"Greene AG, Eivers SB, Dervan EWJ, O\u2019Brien CJ, Wallace DM. Lysyl oxidase like 1: biological roles and regulation. Exp Eye Res. 2020;193:107975. https:\/\/doi.org\/10.1016\/j.exer.2020.107975.","journal-title":"Exp Eye Res"},{"issue":"22","key":"3055_CR23","doi-asserted-by":"publisher","first-page":"6552","DOI":"10.1093\/hmg\/ddv347","volume":"24","author":"MA Hauser","year":"2015","unstructured":"Hauser MA, Aboobakar IF, Liu Y, Miura S, Whigham BT, Challa P, et al. Genetic variants and cellular stressors associated with exfoliation syndrome modulate promoter activity of a lncRNA within the LOXL1 locus. Hum Mol Genet. 2015;24(22):6552\u201363. https:\/\/doi.org\/10.1093\/hmg\/ddv347.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"3055_CR24","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.bbrc.2018.04.133","volume":"500","author":"H Wang","year":"2018","unstructured":"Wang H, Li L, Yin L. Silencing LncRNA LOXL1-AS1 attenuates mesen- chymal characteristics of glioblastoma viaNF-\u03baBpathway. Biochem Biophys Res Commun. 2018;500(2):518\u201324. https:\/\/doi.org\/10.1016\/j.bbrc.2018.04.133.","journal-title":"Biochem Biophys Res Commun"},{"key":"3055_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9275685","volume":"2018","author":"R Gao","year":"2018","unstructured":"Gao R, Zhang R, Zhang C, et al. LncRNA LOXL1-AS1 promotes the proliferation and metastasis of medulloblastoma by activating the PI3K\/ AKT pathway. Anal Cell Pathol (Amst). 2018;2018:9275685. https:\/\/doi.org\/10.1155\/2018\/9275685.","journal-title":"Anal Cell Pathol (Amst)"},{"issue":"6","key":"3055_CR26","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1007\/s10528-022-10226-3","volume":"60","author":"T Guo","year":"2022","unstructured":"Guo T, Peng S, Liu D, Li Y. Long non-coding RNA LOXL1-AS1 facilitates colorectal cancer progression via regulating miR-1224-5p\/miR-761\/HK2 axis. Biochem Genet. 2022;60(6):2416\u201333. https:\/\/doi.org\/10.1007\/s10528-022-10226-3.","journal-title":"Biochem Genet"},{"issue":"2","key":"3055_CR27","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/jcmm.17106","volume":"26","author":"B Yi","year":"2022","unstructured":"Yi B, Li H, Cai H, Lou X, Yu M, Li Z. LOXL1-AS1 communicating with TIAR modulates vasculogenic mimicry in glioma via regulation of the miR-374b-5p\/MMP14 axis. J Cell Mol Med. 2022;26(2):475\u201390. https:\/\/doi.org\/10.1111\/jcmm.17106.","journal-title":"J Cell Mol Med"},{"issue":"7","key":"3055_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.14715\/cmb\/2023.69.7.8","volume":"69","author":"T Chen","year":"2023","unstructured":"Chen T, Zeng S, Liu Q, Chen Y, Lu J. LOXL1-AS1 promotes cell proliferation in hepatocellular carcinomathrough miR-1224-5p\/ITPRIPL2\/AKT axis. Cell Mol Biol (Noisy-le-grand). 2023;69(7):45\u201350. https:\/\/doi.org\/10.14715\/cmb\/2023.69.7.8.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"1","key":"3055_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/13813455.2020.1804406","volume":"129","author":"H Bai","year":"2023","unstructured":"Bai H, Li X, Wu S. Up-regulation of long non-coding RNA LOXL1-AS1 functions as an oncogene in cervical squamous cell carcinoma by sponging miR-21. Arch Physiol Biochem. 2023;129(1):143\u20137. https:\/\/doi.org\/10.1080\/13813455.2020.1804406.","journal-title":"Arch Physiol Biochem"},{"issue":"5","key":"3055_CR30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1136\/jmg-2022-108898","volume":"60","author":"H Hanson","year":"2023","unstructured":"Hanson H, Kulkarni A, Loong L, Kavanaugh G, Torr B, Allen S, et al. UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2. J Med Genet. 2023;60(5):417\u201329. https:\/\/doi.org\/10.1136\/jmg-2022-108898.","journal-title":"J Med Genet"},{"key":"3055_CR31","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.2147\/DDDT.S448707","volume":"18","author":"J Zhang","year":"2024","unstructured":"Zhang J, Wu L, Wang C, Xie X, Han Y. Research progress of long non-coding RNA in tumor drug resistance: a new paradigm. Drug Des Devel Ther. 2024;18:1385\u201398. https:\/\/doi.org\/10.2147\/DDDT.S448707.","journal-title":"Drug Des Devel Ther"},{"issue":"12","key":"3055_CR32","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1093\/hmg\/ddaa021","volume":"29","author":"HM Schmitt","year":"2020","unstructured":"Schmitt HM, Johnson WM, Aboobakar IF, Strickland S, Gomez-Caraballo M, Parker M, et al. Identification and activity of the functional complex between hnRNPL and the pseudoexfoliation syndrome-associated lncRNA, LOXL1-AS1. Hum Mol Genet. 2020;29(12):1986\u201395. https:\/\/doi.org\/10.1093\/hmg\/ddaa021.","journal-title":"Hum Mol Genet"},{"key":"3055_CR33","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.2217\/fon-2016-0542","volume":"13","author":"R Pei","year":"2017","unstructured":"Pei R, Zhang L, Xie C, Lu Z, Wang G, Yang Z. Prognostic value of Ki-67 expression in patients with extensive-stage small cell lung cancer. Future Oncol. 2017;13:1247\u201352. https:\/\/doi.org\/10.2217\/fon-2016-0542.","journal-title":"Future Oncol"},{"issue":"10","key":"3055_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105848","volume":"23","author":"G Manfioletti","year":"2022","unstructured":"Manfioletti G, Fedele M. Epithelial-Mesenchymal transition (EMT) 2021. Int J Mol Sci. 2022;23(10):5848. https:\/\/doi.org\/10.3390\/ijms23105848.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3055_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/(SICI)1097-4652(199905)179:2<115::AID-JCP1>3.0.CO;2-T","volume":"179","author":"Y Ando-Akatsuka","year":"1999","unstructured":"Ando-Akatsuka Y, Yonemura S, Itoh M, Furuse M, Tsukita S. Differential behavior of E-cadherin and occludin in their colocalization with ZO-1 during the establishment of epithelial cell polarity. J Cell Physiol. 1999;179(2):115\u201325. https:\/\/doi.org\/10.1002\/(SICI)1097-4652(199905)179:2%3c115::AID-JCP1%3e3.0.CO;2-T.","journal-title":"J Cell Physiol"},{"issue":"4","key":"3055_CR36","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/sj.cdd.4400664","volume":"7","author":"R Hoetelmans","year":"2000","unstructured":"Hoetelmans R, van Slooten HJ, Keijzer R, Erkeland S, van de Velde CJ, Dierendonck JH. Bcl-2 and Bax proteins are present in interphase nuclei of mammalian cells. Cell Death Differ. 2000;7(4):384\u201392. https:\/\/doi.org\/10.1038\/sj.cdd.4400664.","journal-title":"Cell Death Differ"},{"issue":"2","key":"3055_CR37","doi-asserted-by":"publisher","first-page":"799","DOI":"10.22092\/ARI.2022.357090.1968","volume":"77","author":"HFS Al-Zubaidy","year":"2022","unstructured":"Al-Zubaidy HFS, Majeed SR, Al-Koofee DAF. Evaluation of Bax and BCL 2 genes polymorphisms in Iraqi women with breast cancer. Arch Razi Inst. 2022;77(2):799\u2013808. https:\/\/doi.org\/10.22092\/ARI.2022.357090.1968.","journal-title":"Arch Razi Inst"},{"issue":"5645","key":"3055_CR38","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1126\/science.1088753","volume":"302","author":"X Yu","year":"2023","unstructured":"Yu X, Chini CCS, He M, Mer G, Chen J. The BRCT domain is a phospho-protein binding domain. Sci. 2023;302(5645):639\u201342. https:\/\/doi.org\/10.1126\/science.1088753.","journal-title":"Sci"},{"issue":"1","key":"3055_CR39","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/s0092-8674(01)00304-x","volume":"105","author":"SB Cantor","year":"2001","unstructured":"Cantor SB, Bell DW, Ganesan S, Kass EM, Drapkin R, Grossman S, et al. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell. 2001;105(1):149\u201360. https:\/\/doi.org\/10.1016\/s0092-8674(01)00304-x.","journal-title":"Cell"},{"issue":"3","key":"3055_CR40","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/cncr.32572","volume":"126","author":"V Vysotskaia","year":"2020","unstructured":"Vysotskaia V, Kaseniit KE, Bucheit L, Ready K, Price K, Johansen Taber K. Clinical utility of hereditary cancer panel testing: impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations. Cancer. 2020;126(3):549\u201358. https:\/\/doi.org\/10.1002\/cncr.32572.","journal-title":"Cancer"},{"issue":"1","key":"3055_CR41","doi-asserted-by":"publisher","first-page":"4435","DOI":"10.1038\/s41598-023-31109-6","volume":"13","author":"G Long","year":"2023","unstructured":"Long G, Hu K, Zhang X, Zhou L, Li J. Spectrum of BRCA1 interacting helicase 1 aberrations and potential prognostic and therapeutic implication: a pan cancer analysis. Sci Rep. 2023;13(1):4435. https:\/\/doi.org\/10.1038\/s41598-023-31109-6.","journal-title":"Sci Rep"},{"issue":"9","key":"3055_CR42","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/ng0905-921","volume":"37","author":"LH Thompson","year":"2005","unstructured":"Thompson LH. Unraveling the Fanconi anemia-DNA repair connection. Nat Genet. 2005;37(9):921\u20132. https:\/\/doi.org\/10.1038\/ng0905-921.","journal-title":"Nat Genet"},{"issue":"2","key":"3055_CR43","doi-asserted-by":"publisher","first-page":"101042831769118","DOI":"10.1177\/1010428317691187","volume":"39","author":"H Dang","year":"2017","unstructured":"Dang H, Zheng P, Liu Y, Wu X, Wu X. Microrna-543 acts as a prognostic marker and promotes the cell proliferation in cervical cancer by BRCA1-interacting protein 1. Tumour Biol. 2017;39(2):1010428317691187. https:\/\/doi.org\/10.1177\/1010428317691187.","journal-title":"Tumour Biol"},{"issue":"1","key":"3055_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12957-022-02877-8","volume":"21","author":"R Wang","year":"2023","unstructured":"Wang R, Zhang J, Cui X, Wang S, Chen T, Niu Y, et al. Multimolecular characteristics and role of BRCA1 interacting protein C-terminal helicase 1 (BRIP1) in human tumors: a pan-cancer analysis. World J Surg Oncol. 2023;21(1):91. https:\/\/doi.org\/10.1186\/s12957-022-02877-8.","journal-title":"World J Surg Oncol"}],"updated-by":[{"DOI":"10.1007\/s12032-026-03289-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000}}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03055-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03055-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03055-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:13:25Z","timestamp":1781842405000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03055-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":44,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["3055"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03055-y","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"13 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In this article, figure 1 is incorrect. In Figure 1A, \u201cOV: n=4\u201d should be corrected to \u201cOV: n=426\u201d, Figure 1B duplicates Figure 3A and should be deleted along with its legend.Figure 1C duplicates Figure 2C and should be deleted along with its legend. The corrected Figure 1 and its legend is updated and results section has been updated.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12032-026-03289-4","URL":"https:\/\/doi.org\/10.1007\/s12032-026-03289-4","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present work gained approval from the Medical Ethics Committee of Wannan Medical College (No. WNMC-AWE-2023434).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The patients offered informed consent for participation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"504"}}